Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steckler

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Springerplus|February 13, 2015
Editorial: preclinical data reproducibility for R&D - the challenge for neuroscienceThomas Steckler
Current Topics in Behavioral Neurosciences|February 11, 2011
Developing small molecule nonpeptidergic drugs for the treatment of anxiety disorders: is the challenge still ahead?Thomas Steckler
Psychopharmacology|January 15, 2015
Preclinical data reproducibility for R&D--the challenge for neuroscienceThomas Steckler
European Journal of Pharmacology|April 8, 2010
Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illnessAnne Lesage, Thomas Steckler
Pharmacology, Biochemistry, and Behavior|March 20, 2002
Cholinergic blockade impairs performance in operant DNMTP in two inbred strains of miceNuria Estapé, Thomas Steckler
Journal of Neuroscience Methods|November 7, 2017
Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?Anton Bespalov, Thomas Steckler
Biological Psychiatry|February 22, 2021
Pharmacology of Anxiety or Pharmacology of Elevated Plus Maze?Anton Bespalov, Thomas Steckler
Nature|April 25, 2019
A European initiative to unclog pipeline for new medicinesMalcolm Macleod, Thomas Steckler
Handbook of Experimental Pharmacology|September 22, 2019
Good Research Practice: Lessons from Animal Care and UseJavier Guillén, Thomas Steckler
Neuropharmacology|July 9, 2011
Pharmacological treatment of PTSD - established and new approachesThomas Steckler, Victoria Risbrough
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Springerplus|February 13, 2015
Editorial: preclinical data reproducibility for R&D - the challenge for neuroscienceThomas Steckler
Current Topics in Behavioral Neurosciences|February 11, 2011
Developing small molecule nonpeptidergic drugs for the treatment of anxiety disorders: is the challenge still ahead?Thomas Steckler
Psychopharmacology|January 15, 2015
Preclinical data reproducibility for R&D--the challenge for neuroscienceThomas Steckler
European Journal of Pharmacology|April 8, 2010
Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illnessAnne Lesage, Thomas Steckler
Pharmacology, Biochemistry, and Behavior|March 20, 2002
Cholinergic blockade impairs performance in operant DNMTP in two inbred strains of miceNuria Estapé, Thomas Steckler
Journal of Neuroscience Methods|November 7, 2017
Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?Anton Bespalov, Thomas Steckler
Biological Psychiatry|February 22, 2021
Pharmacology of Anxiety or Pharmacology of Elevated Plus Maze?Anton Bespalov, Thomas Steckler
Nature|April 25, 2019
A European initiative to unclog pipeline for new medicinesMalcolm Macleod, Thomas Steckler
Handbook of Experimental Pharmacology|September 22, 2019
Good Research Practice: Lessons from Animal Care and UseJavier Guillén, Thomas Steckler
Neuropharmacology|July 9, 2011
Pharmacological treatment of PTSD - established and new approachesThomas Steckler, Victoria Risbrough
Pageof 11